BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 8258318)

  • 1. Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma.
    Blank U; Boitel B; Mège D; Ermonval M; Acuto O
    Eur J Immunol; 1993 Dec; 23(12):3057-65. PubMed ID: 8258318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong similarities in antigen fine specificity among DRB1* 1302-restricted tetanus toxin tt830-843-specific TCRs in spite of highly heterogeneous CDR3.
    Boitel B; Blank U; Mège D; Corradin G; Sidney J; Sette A; Acuto O
    J Immunol; 1995 Apr; 154(7):3245-55. PubMed ID: 7534793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition.
    Boitel B; Ermonval M; Panina-Bordignon P; Mariuzza RA; Lanzavecchia A; Acuto O
    J Exp Med; 1992 Mar; 175(3):765-77. PubMed ID: 1371303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition.
    Vollmer J; Weltzien HU; Moulon C
    J Immunol; 1999 Sep; 163(5):2723-31. PubMed ID: 10453014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules.
    Jones CM; Lake RA; Lamb JR; Faith A
    Eur J Immunol; 1994 May; 24(5):1137-42. PubMed ID: 7514130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted alpha/beta receptor gene usage of idiotype-specific major histocompatibility complex-restricted T cells: selection for CDR3-related sequences.
    Snodgrass HR; Fisher AM; Bruyns E; Bogen B
    Eur J Immunol; 1992 Aug; 22(8):2169-72. PubMed ID: 1379189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of putative complementarity-determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity.
    Patten PA; Rock EP; Sonoda T; Fazekas de St Groth B; Jorgensen JL; Davis MM
    J Immunol; 1993 Mar; 150(6):2281-94. PubMed ID: 7680688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.
    Man S; Ridge JP; Engelhard VH
    J Immunol; 1994 Nov; 153(10):4458-67. PubMed ID: 7963521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell receptor V alpha 4 is expressed by a subpopulation of V beta 6 T cells that respond to the bacterial superantigen staphylococcal enterotoxin B.
    Borrero H; Donson D; Cervera C; Rexer C; Macphail S
    J Immunol; 1995 May; 154(9):4247-60. PubMed ID: 7722285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant.
    Kelly JM; Sterry SJ; Cose S; Turner SJ; Fecondo J; Rodda S; Fink PJ; Carbone FR
    Eur J Immunol; 1993 Dec; 23(12):3318-26. PubMed ID: 8258346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of major histocompatibility complex class I-restricted hapten recognition by mutation of the V-J joining of T cell receptor alpha chains.
    von Bonin A; Plaga S; Ruh H; Hebbelmann S; Pflugfelder U; Martin S; Weltzien HU
    Eur J Immunol; 1996 Jan; 26(1):179-86. PubMed ID: 8566064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A; Schirmbeck R; Reimann J
    Eur J Immunol; 1994 May; 24(5):1172-80. PubMed ID: 7514132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.
    Solheim JC; Alexander-Miller MA; Martinko JM; Connolly JM
    J Immunol; 1993 Feb; 150(3):800-11. PubMed ID: 8380825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial superantigen specificities of mouse T cell receptor V beta 20.
    Bravo de Alba Y; Cazenave PA; Marche PN
    Eur J Immunol; 1995 Dec; 25(12):3425-30. PubMed ID: 8566033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal heterogeneity of superantigen reactivity in human V beta 6+ T cell clones. Limited contributions of V beta sequence polymorphisms.
    Goronzy JJ; Oppitz U; Weyand CM
    J Immunol; 1992 Jan; 148(2):604-11. PubMed ID: 1530864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
    Karp DR; Teletski CL; Scholl P; Geha R; Long EO
    Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
    Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
    Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted T cell receptor expression by human T cell clones specific for mycobacterial 65-kDa heat-shock protein: selective in vivo expansion of T cells bearing defined receptors.
    Henwood J; Loveridge J; Bell JI; Gaston JS
    Eur J Immunol; 1993 Jun; 23(6):1256-65. PubMed ID: 7684683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.